IOVA — Iovance Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Iovance Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	629	504	472	280	324
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0.151	69.3
Total Inventory
Prepaid Expenses
Total Current Assets	636	508	479	308	457
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	114	170	178	177	164
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	768	777	664	780	910
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	54.9	89.2	91.5	110	122
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	112	156	164	196	200
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	656	622	500	585	710
Total Liabilities & Shareholders' Equity	768	777	664	780	910
Total Common Shares Outstanding
Total Preferred Shares Outstanding